CNTX logo

Context Therapeutics Inc. (CNTX)

Profile

Full Name

Context Therapeutics Inc.

Ticker

NASDAQ: CNTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 20, 2021

Indexes

Not included

Website

https://www.contexttherapeutics.com

Employees

12

Key Details

Price

$1.20(-5.51%)

Market Cap

$110.26M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.46(69.52% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.20
    CNTX price is $1.20

    30-Day Relative Volume

    1.05
    CNTX 30-day relative volume is 1.05

    Price Performance

    Price Most Recent Change

    -5.51%
    CNTX price was down -5.51% on Dec 22, 2025

    Price YTD Change

    +14.29%
    CNTX price is up +14.29% since January 1st

    Price 1-Year Change

    +17.65%
    CNTX price is up +17.65% year-on-year

    Price 3-Year Change

    +94.17%
    CNTX price is up +94.17% over the past 3 years

    Price Range

    Price All-Time High

    $10.87
    CNTX price is currently -88.96% below its historical high of $10.87

    Price 3-Year Low

    $0.47
    CNTX price is currently +155.32% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $110.26M
    CNTX market cap is $110.26 million

    Market Cap 3-Year Change

    +1017.41%
    CNTX market cap is up +1017.41% over the past 3 years

    Market Cap All-Time High

    $199.50M
    CNTX market cap is currently -44.73% below its historical high of $199.50 million

    Market Cap Sector Percentile

    41.25%
    CNTX market cap is higher than 41.25% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +22.51%
    CNTX shares outstanding is up +22.51% year-on-year

    Shares Outstanding 3-Year Change

    +475.46%
    CNTX shares outstanding is up +475.46% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.11
    CNTX beta is 1.11

    200-day SMA

    $0.88
    CNTX price is currently +36.52% above its 200-day simple moving average

    50-day SMA

    $1.16
    CNTX price is currently +3.38% above its 50-day simple moving average

    14-Day RSI

    56.41
    CNTX 14-day relative strength index is 56.41

    Volume

    1.05
    CNTX 30-day relative volume is 1.05

    ATR

    $0.10
    CNTX average true range is $0.10

    10-day Historical Volatility

    82.67%
    CNTX 10-day historical volatility is 82.67%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CNTX annual revenue is $0.00

    Revenue Analysts Estimate

    -
    CNTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    CNTX annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.49%
    CNTX annual revenue is higher than 28.49% of companies in Healthcare sector

    EPS

    EPS

    -$0.46
    CNTX annual earnings per share is -$0.46

    EPS Analysts Estimate

    -$0.35
    CNTX annual earnings per share is currently -30.71% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +69.52%
    CNTX annual earnings per share is up +69.52% year-on-year

    EPS Sector Percentile

    68.52%
    CNTX annual earnings per share is higher than 68.52% of companies in Healthcare sector

    Profit

    Gross Profit

    -$52.70K
    CNTX annual gross profit is -$52.70 thousand

    Gross Margin

    -
    CNTX annual gross profit margin value is unknown

    Operating Profit

    -$29.92M
    CNTX annual operating income is -$29.92 million

    Operating Margin

    -
    CNTX annual operating profit margin value is unknown

    Net Income

    -$26.73M
    CNTX annual net profit is -$26.73 million

    Net Margin

    -
    CNTX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $29.92M
    CNTX annual total expenses is $29.92 million

    Operating Expenses

    $29.92M
    CNTX annual total operating expenses is $29.92 million

    Cost Of Goods Sold

    $52.70K
    CNTX annual cost of goods sold is $52.70 thousand

    Selling, General & Administrative Expenses

    $7.22M
    CNTX annual SG&A is $7.22 million

    Depreciation & Amortization

    $52.70K
    CNTX annual D&A is $52.70 thousand

    Interest Expense

    $0.00
    CNTX annual interest expense is $0.00

    Income Tax

    $0.00
    CNTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$29.92M
    CNTX annual earnings before interest & taxes is -$29.92 million

    EBITDA

    -$29.91M
    CNTX annual EBITDA is -$29.91 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $98.13M
    CNTX annual total assets is $98.13 million

    Non Current Assets

    $230.80K
    CNTX annual long term assets is $230.80 thousand

    Current Assets

    $97.90M
    CNTX annual total current assets is $97.90 million

    Cash and Cash Equivalents

    $94.43M
    CNTX annual cash & cash equivalents is $94.43 million

    Accounts Receivable

    -
    CNTX annual accounts receivable value is unknown

    Inventory

    $0.00
    CNTX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $2.86M
    CNTX annual total liabilities is $2.86 million

    Long Term Liabilities

    $112.10K
    CNTX annual total long term liabilities is $112.10 thousand

    Current Liabilities

    $2.75M
    CNTX annual current liabilities is $2.75 million

    Accounts Payable

    $1.45M
    CNTX annual accounts payable is $1.45 million

    Debt

    Total Debt

    $219.40K
    CNTX annual total debt is $219.40 thousand

    Total Debt 1-Year Change

    +100%
    CNTX annual total debt is up +100% year-on-year

    Long Term Debt

    $112.10K
    CNTX annual long term debt is $112.10 thousand

    Short Term Debt

    $107.30K
    CNTX annual short term debt is $107.30 thousand

    Equity & Capital

    Shareholders Equity

    $95.27M
    CNTX annual stockholders equity is $95.27 million

    Book Value

    $95.27M
    CNTX annual book value is $95.27 million

    Retained Earnings

    -$94.78M
    CNTX annual retained earnings is -$94.78 million

    Working Capital

    $94.95M
    CNTX annual working capital is $94.95 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$14.56M
    CNTX annual cash from operations is -$14.56 million

    Cash From Operations 1-Year Change

    +30.84%
    CNTX annual cash from operations is up +30.84% year-on-year

    Cash From Investing

    -$14.76M
    CNTX annual cash from investing is -$14.76 million

    Cash From Investing 1-Year Change

    -100%
    CNTX annual cash from investing is down -100% year-on-year

    Cash From Financing

    $109.29M
    CNTX annual cash from financing is $109.29 million

    Cash From Financing 1-Year Change

    +100%
    CNTX annual cash from financing is up +100% year-on-year

    CAPEX

    CAPEX

    $14.76M
    CNTX annual capital expenditures is $14.76 million

    CAPEX 1-Year Change

    +100%
    CNTX annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$29.31M
    CNTX annual free cash flow is -$29.31 million

    Free Cash Flow 1-Year Change

    -39.27%
    CNTX annual free cash flow is down -39.27% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    CNTX annual gross profit margin value is unknown

    Operating Margin

    -
    CNTX annual operating profit margin value is unknown

    Net Margin

    -
    CNTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -46.81%
    CNTX annual return on assets is -46.81%

    ROE

    -49.89%
    CNTX annual return on equity is -49.89%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CNTX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CNTX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.51
    CNTX price to book ratio is 1.51

    PB Ratio Sector Percentile

    44.03%
    CNTX price to book ratio is higher than 44.03% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    CNTX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    CNTX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $33.46M
    CNTX enterprise value is $33.46 million

    Enterprise Value Sector Percentile

    31.4%
    CNTX enterprise value is higher than 31.4% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.11
    CNTX EV/EBITDA is -1.11

    EV/EBITDA Sector Percentile

    46.47%
    CNTX EV/EBITDA is higher than 46.47% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    35.55
    CNTX annual current ratio is 35.55

    Quick Ratio

    35.62
    CNTX annual quick ratio is 35.62

    Leverage

    Debt To Equity

    0.00
    CNTX annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    CNTX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    CNTX piotroski f-score value is unknown

    Altman Z-Score

    21.93
    CNTX altman z-score is 21.93

    Analyst ratings

    Recent major analysts updates

    Nov 6, 25 HC Wainwright & Co.
    Buy
    Nov 6, 25 D. Boral Capital
    Buy
    Oct 16, 25 D. Boral Capital
    Buy
    Oct 2, 25 Cantor Fitzgerald
    Overweight
    Sep 18, 25 Guggenheim
    Buy
    Aug 7, 25 HC Wainwright & Co.
    Buy
    Aug 7, 25 D. Boral Capital
    Buy
    Jun 26, 25 Piper Sandler
    Overweight
    May 8, 25 D. Boral Capital
    Buy
    Apr 29, 25 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with CNTX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Context Therapeutics Inc.?
    • Does Context Therapeutics Inc. pay dividends?
    • What sector is Context Therapeutics Inc. in?
    • What industry is Context Therapeutics Inc. in?
    • What country is Context Therapeutics Inc. based in?
    • When did Context Therapeutics Inc. go public?
    • Is Context Therapeutics Inc. in the S&P 500?
    • Is Context Therapeutics Inc. in the NASDAQ 100?
    • Is Context Therapeutics Inc. in the Dow Jones?
    • When was Context Therapeutics Inc.'s last earnings report?
    • When does Context Therapeutics Inc. report earnings?

    What is the ticker symbol for Context Therapeutics Inc.?

    The ticker symbol for Context Therapeutics Inc. is NASDAQ:CNTX

    Does Context Therapeutics Inc. pay dividends?

    No, Context Therapeutics Inc. does not pay dividends

    What sector is Context Therapeutics Inc. in?

    Context Therapeutics Inc. is in the Healthcare sector

    What industry is Context Therapeutics Inc. in?

    Context Therapeutics Inc. is in the Biotechnology industry

    What country is Context Therapeutics Inc. based in?

    Context Therapeutics Inc. is headquartered in United States

    When did Context Therapeutics Inc. go public?

    Context Therapeutics Inc.'s initial public offering (IPO) was on October 20, 2021

    Is Context Therapeutics Inc. in the S&P 500?

    No, Context Therapeutics Inc. is not included in the S&P 500 index

    Is Context Therapeutics Inc. in the NASDAQ 100?

    No, Context Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Context Therapeutics Inc. in the Dow Jones?

    No, Context Therapeutics Inc. is not included in the Dow Jones index

    When was Context Therapeutics Inc.'s last earnings report?

    Context Therapeutics Inc.'s most recent earnings report was on November 10, 2022

    When does Context Therapeutics Inc. report earnings?

    The date for Context Therapeutics Inc.'s next earnings report has not been announced yet
    On this page